Codman Neuro, a part of DePuy Synthes Companies of Johnson & Johnson, has signed an exclusive distribution agreement with Pulsar Vascular to sell its PulseRider in Europe, the Middle East and Africa.
The agreement has been signed by one of Codman Neuro’s EU affiliated companies.
PulseRider is a self-expanding nitinol implant, which can be used in conjunction with embolic coils in the treatment of unruptured wide-neck intracranial aneurysms originating on or near a bifurcation.
Codman Neuro worldwide president Laxmin Laxminarain said that there is a significant unmet clinical need in the treatment of unruptured wide-neck bifurcation aneurysms.
"We are excited about this new agreement with Pulsar Vascular and the greater access physicians and their patients in Europe will now have to a potentially lifesaving endovascular procedure," Laxminarain added.
The US Food and Drug Administration (FDA) has not approved Pulsar Vascular and is limited to investigational use only in the US.
In late 2013, the device secured CE mark approval in Europe.
Codman Neuro provides devices for hydrocephalus management, neuro intensive care and cranial surgery, as well as aneurysm coils and vascular reconstruction devices.